These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2286970)

  • 1. Behçet's syndrome treated with high-dose intravenous IgG and low-dose aspirin.
    Rewald E; Jaksic JC
    J R Soc Med; 1990 Oct; 83(10):652-3. PubMed ID: 2286970
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of Behçet's disease with pulmonary arterial aneurysm and secondary amyloidosis.
    Aksu K; Koçanaoğullari H; Keser G; Inal V; Kabasakal Y; Oksel F; Gümüşdiş G; Doğanavşargil E
    Rheumatology (Oxford); 2002 Jul; 41(7):831-2. PubMed ID: 12096241
    [No Abstract]   [Full Text] [Related]  

  • 3. A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.
    Alty JE; Monaghan TM; Bamford JM
    Clin Neurol Neurosurg; 2007 Apr; 109(3):279-81. PubMed ID: 17174468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behçet's syndrome: response to infliximab after failure of etanercept.
    Estrach C; Mpofu S; Moots RJ
    Rheumatology (Oxford); 2002 Oct; 41(10):1213-4. PubMed ID: 12364656
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.
    Buggage RR; Levy-Clarke G; Sen HN; Ursea R; Srivastava SK; Suhler EB; Altemare C; Velez G; Ragheb J; Chan CC; Nussenblatt RB; Bamji AT; Sran P; Waldmann T; Thompson DJ
    Ocul Immunol Inflamm; 2007; 15(2):63-70. PubMed ID: 17558830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication].
    van Laar JA; Jamnitski A; Baarsma GS; van Daele PL; van Hagen PM
    Ned Tijdschr Geneeskd; 2006 Apr; 150(13):705-9. PubMed ID: 16623340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of mucocutaneous Behçet's disease responding to etanercept.
    Sommer A; Altmeyer P; Kreuter A
    J Am Acad Dermatol; 2005 Apr; 52(4):717-9. PubMed ID: 15793540
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of resistant Behçet's disease with etanercept.
    Atzeni F; Sarzi-Puttini P; Capsoni F; Mecchia M; Marrazza MG; Carrabba M
    Clin Exp Rheumatol; 2005; 23(5):729. PubMed ID: 16173263
    [No Abstract]   [Full Text] [Related]  

  • 9. Unilateral erythema nodosum-like lesions and superficial thrombophlebitis together with ipsilateral thrombosis of the vena femoralis in Behçet's disease.
    Akman A; Yilmaz E; Ciftcioglu MA; Alpsoy E
    Eur J Dermatol; 2006; 16(6):703-4. PubMed ID: 17229626
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologics and Behcet's: disease diversity and trial design.
    Rosenbaum JT
    Ocul Immunol Inflamm; 2007; 15(2):61-2. PubMed ID: 17558829
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease.
    Delunardo F; Conti F; Margutti P; Alessandri C; Priori R; Siracusano A; Riganò R; Profumo E; Valesini G; Sorice M; Ortona E
    Arthritis Res Ther; 2006; 8(3):R71. PubMed ID: 16611372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric neuro-Behçet's disease responsive to adalimumab.
    Robinson AB; Gallentine WB; Rabinovich CE
    Pediatr Neurol; 2010 Oct; 43(4):291-3. PubMed ID: 20837311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of etanercept in the treatment of a patient with Behçet's disease.
    Curigliano V; Giovinale M; Fonnesu C; Cerquaglia C; Verrecchia E; Turco S; Manganelli C; Manna R
    Clin Rheumatol; 2008 Jul; 27(7):933-6. PubMed ID: 18330611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary artery aneurysms in Behçet's disease.
    Yilmaz S; Cimen KA
    Rheumatol Int; 2010 Aug; 30(10):1401-3. PubMed ID: 19693504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Behcet's syndrome--summary].
    Shikano S
    Saishin Igaku; 1971 Mar; 26(3):525-7. PubMed ID: 5547393
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behçet's disease in childhood--case reports and review of literature].
    Mori M; Shimizu C; Kuriyama T; Ibe M; Mitsuda T; Aihara Y; Yokota S
    Ryumachi; 1994 Feb; 34(1):34-41. PubMed ID: 8146726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New therapeutic prospectives in Behçet's disease: beta-interferon].
    Tata F; Gori E; De Bartolomeis AM; Mari MV
    Recenti Prog Med; 1988 Mar; 79(3):135-7. PubMed ID: 3393721
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cutaneous manifestations of Behçet's syndrome].
    Miki Y; Kawatsu T
    Nihon Ganka Kiyo; 1971 Oct; 22(10):898-902. PubMed ID: 5169256
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behçet's disease and its treatment].
    Wechsler B; Lê Thi Huong Du; Godeau P
    Ann Med Interne (Paris); 1992; 143(7):426-7. PubMed ID: 1300860
    [No Abstract]   [Full Text] [Related]  

  • 20. Behçet's syndrome: from aetiology to treatment.
    Powell RJ
    Adv Exp Med Biol; 2003; 528():481-6. PubMed ID: 12918749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.